Acorda Therapeutics, Inc. (ACOR)
$23.78
0.32 (+1.36%)
| CAPS Rating |
|
|---|---|
| Open | $23.42 |
| Previous Close | $23.46 |
| Daily Range | $23.08 - $23.78 |
| 52-Week Range | $14.42 - $29.27 |
| Market Cap | $905.17M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 376,502 |
| Average Daily Volume | 1,937,000 |
ACOR
VS S&P 500 (SPY)
How do you think ACOR will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
ACOR Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
ACOR News and Commentary
- A Little Distracted, Are You, Merck? – The Motley Fool
- Enzyme eats scar tissue that blocks spine repair – Reuters
- CNBC on Acorda Therapeutics, Inc. – Ockham-RazorWire
- CNBC on Acorda Therapeutics, Inc. – Ockham-RazorWire
- Small Market, Small Acquisition, Still a Good Move – The Motley Fool
- Elan's Headed in the Right Direction – The Motley Fool
- UPDATE 1-FDA extends review date of Acorda's MS drug by 3 months – Reuters
- Little Discord on Acorda Drug – The Motley Fool
- UPDATE 1-Acorda shares soar after FDA panel backs MS drug – Reuters
- U.S. FDA panel supports Acorda MS drug – Reuters
- UPDATE 1-US FDA staff: limited effect with Acorda MS drug – Reuters
- Acorda's Upcoming Excitement – The Motley Fool
- 5 Deathbed Stocks? – The Motley Fool
- Tysabri Is Back! – The Motley Fool
- Deal Struck, Shares Stuck – The Motley Fool
- Deathbed Stocks Revisited – The Motley Fool
- 7 Stocks Defying the Doubters – The Motley Fool
- Closing ACOR (Acorda) outperform – Blog at The Motley Fool
- Taking a Walk With a 10-Bagger – The Motley Fool
- Surprising Low-Rated Stocks the Leaders Love – The Motley Fool
RSS Headlines
Fool UK
